Literature DB >> 5242941

[Chemotherapy of malignant blood diseases].

H Ehrhart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5242941     DOI: 10.1007/bf01727394

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  49 in total

1.  [EXPERIENCE WITH ETHYLENEIMINES].

Authors:  D GERICKE
Journal:  Neoplasma       Date:  1964       Impact factor: 2.575

Review 2.  ANTIMETABOLITES IN THE CHEMOTHERAPY OF LEUKEMIA.

Authors:  F M HUENNEKENS; J R BERTINO; R SILBER; B W GABRIO
Journal:  Exp Cell Res       Date:  1963       Impact factor: 3.905

Review 3.  STUDIES RELATED TO MECHANISMS OF RESISTANCE TO BIOLOGICAL ALKYLATING AGENTS.

Authors:  G P WHEELER
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

4.  [PRINCIPLES OF CHEMOTHERAPEUTIC TREATMENT OF NEOPLASTIC DISEASES].

Authors:  K W BRUNNER
Journal:  Schweiz Med Wochenschr       Date:  1965-06-12

5.  Dangers of uric-acid excretion during treatment of leukaemia and lymphosarcoma.

Authors:  D GREENBAUM; H F H STONE
Journal:  Lancet       Date:  1959-01-10       Impact factor: 79.321

6.  [Cortisone, pregnancy and abnormalities in the newborn].

Authors:  H LOHMEYER
Journal:  Geburtshilfe Frauenheilkd       Date:  1961-06       Impact factor: 2.915

7.  A decade of chemotherapeutic control of acute leukemia.

Authors:  J R SAMPEY
Journal:  Int Rec Med       Date:  1960-05

Review 8.  [The present-day use of cytostatics in clinical and general practice].

Authors:  S Moeschlin
Journal:  Med Klin       Date:  1965-07-23

9.  Acute leukemia.

Authors:  R A Kyle; J E Maldonado
Journal:  Mayo Clin Proc       Date:  1966-06       Impact factor: 7.616

10.  [Steroid therapy in hematologic diseases and neoplasms].

Authors:  H Huber; K Goldberg; H Fellner
Journal:  Med Welt       Date:  1965-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.